Enteropathogenic E.coli (EPEC) and enterohaemorrhagic E. coli (EHEC O157:H7) are deadly contaminants in food and water world wide causing diarrhea and death. Formation of actin-filled membrane """"""""pedestals"""""""" (also called """"""""A/E lesions"""""""") beneath EPEC and EHEC are essential for the development of disease. Tyrosine phosphorylation by an unidentified host cell kinase of a translocated bacterial virulence factor, called Tir, is essential for EPEC pedestal formation. Our preliminary evidence indicates (i) that the cellular kinase resembles Abl, but that other tyrosine kinases may also suffice, (ii) that Abl or a related kinase regulates both EPEC and EHEC pathogenesis, and (iii) that PD compounds, which inhibit Abl kinase and are being developed to treat cancer caused by dysregulated Abl, block pathogenic effects in vitro of EPEC and EHEC, and of C. rodentium, a related pathogen that forms A/E lesions in mice. The goal of Aim I is to identify redundant Abl-like kinases. The goal of Aim II is to determine how Abl kinase regulates formation of A/E lesions. Such information will prove essential to understanding the physiological mechanisms of A/E lesion formation, and will inform the design of even more specific inhibitors useful in treating not only bacterial infections but also cancers caused by dysregulated tyrosine kinases. The goal of Aim III is to establish the efficacy of PD inhibitors in mice infected with C. rodentium. Such experiments are an important prelude to clinical testing of drug efficacy in human patients infected with EPEC or EHEC. The need is apparent. EPEC and EHEC are classified by the NIAID as Category B pathogens. In developing countries, antibiotics and rehydration therapy are generally unavailable to treat EPEC infections, and a requirement for high patient compliance further reduces their efficacy when they are available. For EHEC, antibiotics exacerbate symptoms perhaps by lysing bacteria and releasing toxins and, in the United States, are contraindicated. Furthermore, drug-resistant EHEC strains have been documented. In this regard, because PD compounds affect the host and not the bacterium, selecting resistant strains with PD is far less likely than with conventional antibiotics or antimicrobial compounds. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI056067-03
Application #
6864888
Study Section
Special Emphasis Panel (ZRG1-BM-1 (05))
Program Officer
Schmitt, Clare K
Project Start
2003-09-01
Project End
2008-02-29
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
3
Fiscal Year
2005
Total Cost
$344,250
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Hawn, Thomas R; Shah, Javeed A; Kalman, Daniel (2015) New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev 264:344-62
Bommarius, Bettina; Anyanful, Akwasi; Izrayelit, Yevgeniy et al. (2013) A family of indoles regulate virulence and Shiga toxin production in pathogenic E. coli. PLoS One 8:e54456
Wilson, Jarad J; Lin, Eugene; Pack, Christopher D et al. (2011) Gamma interferon controls mouse polyomavirus infection in vivo. J Virol 85:10126-34
Napier, Ruth J; Rafi, Wasiulla; Cheruvu, Mani et al. (2011) Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe 10:475-85
Bhatt, Shantanu; Romeo, Tony; Kalman, Daniel (2011) Honing the message: post-transcriptional and post-translational control in attaching and effacing pathogens. Trends Microbiol 19:217-24
Swimm, Alyson I; Bornmann, William; Jiang, Mengxi et al. (2010) Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus. J Virol 84:4243-51
Lebeis, Sarah L; Powell, Kimberly R; Merlin, Didier et al. (2009) Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 77:604-14
Lebeis, Sarah L; Kalman, Daniel (2009) Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions. Cell Host Microbe 5:114-22
Anyanful, Akwasi; Easley, Kirk A; Benian, Guy M et al. (2009) Conditioning protects C. elegans from lethal effects of enteropathogenic E. coli by activating genes that regulate lifespan and innate immunity. Cell Host Microbe 5:450-62
Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Powell, Kimberly R et al. (2009) Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response. Gastroenterology 137:1435-47.e1-2

Showing the most recent 10 out of 18 publications